Scientists investigate Cholesterol's role in dementia progression

NCT ID NCT07207486

Recruiting now Knowledge-focused Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 26 times

Summary

This study looks at how cholesterol and its byproducts may be linked to the development and worsening of dementias like Alzheimer's. Researchers will measure these substances in brain tissue, spinal fluid, and blood from 80 adults aged 40-85 with different types of dementia. The goal is to find patterns that could help diagnose or track the disease, not to test a treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEMENTIAS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Fondazione IRCCS Istituto Neurologico Carlo Besta
RECRUITING

Milan, 20133, Italy

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••
Università di Torino AOU San Luigi Gonzaga
WITHDRAWN

Torino, to, 10043, Italy

Conditions

Explore the condition pages connected to this study.

DEMENTIAS DEMENTIAS NEURODEGENERATIVE DEMENTIA